Un nuevo informe mide el alcance del daño de los errores médicos
JUEVES, 20 de julio de 2023 (HealthDay News) — Alrededor de 795,000 estadounidenses mueren o quedan con una discapacidad permanente cada año debido a afecciones médicas mal diagnosticadas. Un nuevo análisis, dirigido por expertos de Johns Hopkins Med…
Learn MoreStudy IDs Factors Explaining Inequity in CVD Mortality in Cancer Survivors
FRIDAY, July 21, 2023 (HealthDay News) — Socioeconomic status and insurance explain a considerable proportion of the inequity in cardiovascular disease (CVD) mortality among Black versus White cancer survivors, according to a study published online J…
Learn MoreStudy IDs Factors Explaining Inequity in CVD Mortality in Cancer Survivors
FRIDAY, July 21, 2023 (HealthDay News) — Socioeconomic status and insurance explain a considerable proportion of the inequity in cardiovascular disease (CVD) mortality among Black versus White cancer survivors, according to a study published online J…
Learn MoreComposite Inflammatory Biomarker Linked to Dementia Risk
FRIDAY, July 21, 2023 (HealthDay News) — Higher levels of a composite inflammatory biomarker are associated with an increased subsequent risk for dementia, according to a study published online July 19 in PLOS ONE.Krisztina Mekli, Ph.D., from the Cat…
Learn MoreComposite Inflammatory Biomarker Linked to Dementia Risk
FRIDAY, July 21, 2023 (HealthDay News) — Higher levels of a composite inflammatory biomarker are associated with an increased subsequent risk for dementia, according to a study published online July 19 in PLOS ONE.Krisztina Mekli, Ph.D., from the Cat…
Learn MoreKetamine Efficacious for Treatment-Resistant Depression
FRIDAY, July 21, 2023 (HealthDay News) — A four-week treatment course of racemic ketamine is efficacious and safe for treatment-resistant depression (TRD), according to a study published online July 14 in the British Journal of Psychiatry.Colleen Loo…
Learn MoreKetamine Efficacious for Treatment-Resistant Depression
FRIDAY, July 21, 2023 (HealthDay News) — A four-week treatment course of racemic ketamine is efficacious and safe for treatment-resistant depression (TRD), according to a study published online July 14 in the British Journal of Psychiatry.Colleen Loo…
Learn MoreTechnical Variant Graft Usage Affects Pediatric Liver Transplant Waitlist Mortality
FRIDAY, July 21, 2023 (HealthDay News) — For pediatric liver transplant (LT) candidates, higher technical variant graft (TVG; including living donor [LD] and deceased donor split/partial grafts) usage is associated with lower waitlist (WL) mortality,…
Learn MoreBreast Cancer Survivors Age Faster Biologically Than Cancer-Free Women: Study
FRIDAY, July 21, 2023 (HealthDay News) — Women who have survived breast cancer age faster than women who have never had to survive the disease.The treatment they received impacted their aging rates, according to a new study from Moffitt Cancer Center…
Learn MoreHow NSAIDs Can Make a C. Difficile Infection Worse
FRIDAY, July 21, 2023 (HealthDay News) — Aspirin, naproxen and other common pain medications known as NSAIDs worsen gastrointestinal infections caused by a bacterium known as Clostridioides difficile (C. diff), new research shows.NSAIDs (nonsteroidal…
Learn More